STEMRIM |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 419 JPY | -7.51% |
|
-9.50% | -27.51% |
| 09/05 | StemRIM to Seek Shareholders' Approval on Capital Stock Reduction | MT |
| 13/03 | StemRIM Announces Initiation of Phase 2 Clinical Trial for Redasemtide in Ischemic Cardiomyopathy | CI |
- Stock Market
- Equities
- 4599 Stock
- News StemRIM
- Transcripts
